Glucagon-like peptide1(GLP-1), a gastrointestinal peptide and central mediator of glucose metabolism, is secreted by L cells in the intestine in response to food intake. Postprandial secretion ofGLP-1is triggered by nutrient-sensing via transporters and G-protein-coupled receptors (GPCRs).GLP-1secretion may be lower in adults with obesity/overweight (OW) or type 2 diabetes mellitus (T2DM ...
Becauseofthe actions ofGLP-1on stimulatinginsulinsecretion and promoting weight loss,GLP-1andits analogs are used in pharmacologic preparations for the treatment of T2DM.
Mar 1, 2024The conflicting nature of the results is also evident from studies reporting increasedfastingbut decreased meal- or glucose-relatedGLP-1concentrations in T2DM [38] and nonspecified diabetes [51], or unchangedfastingbut reduced early postprandialGLP-1concentrations in participants with lowinsulinsensitivitythan in those with high ...
Dec 13, 2025Intermittentfastingandtime-restricted eating offer physiologically complementary, low-cost strategies that enhance fat oxidation,insulinsensitivity,andmetabolic flexibility while engaging behavioral mechanisms of self-control and dietary regularity.
Jul 12, 20243. Can intermittentfastinghelp manage type 2 diabetes throughGLP-1? Yes, by improvinginsulinsensitivityandglucose regulation, elevatedGLP-1levels fromfastingcan be beneficial for managing type 2 diabetes. 4. Are there risks associated with increasedGLP-1levels from intermittentfasting?
Nov 5, 2025Intermittentfastingis often promoted as a method for losing weight and improving metabolic health.GLP-1receptor agonists such as semaglutide or liraglutide are also used specifically for weight loss. So the obvious question is: can both approaches be combined - or is that too much of a good thing? Whyprolongedintermittentfastingis not recommended duringGLP-1therapy WithGLP-1...
3 days agoThese foods provide essential vitamins and minerals while minimizing empty calories. Avoid processed and sugary foods, which can counteract thebenefitsofGLP-1medications andfasting. Exercise regularly: Combining resistance training and cardiovascular exercise withGLP-1can enhance weight loss and improve body composition.
May 2, 2025Reach Out to Affinity Urgent Care CombiningGLP-1receptor agonist therapy with intermittentfastingholds exciting potential for individuals seeking sustainable weight loss. By harnessing their complementary mechanisms, including hormonal regulation, appetite control, andinsulinsensitivity, patients may experience enhancedbenefits.
Introduction: Glucagon-like peptide-1 hormone (GLP-1) contributes to the regulation ofinsulinandglucose concentration. However, the effects offastingonGLP-1response in different people has ...
Jul 8, 2024Few data are available on the effect of glucagon-like peptide1receptor agonists on lipid metabolism, and no information is available on the postprandial lipidomic profile. In adults without diabetes but with severe obesity, 3-month treatment with exenatideimprovedfastingandpostprandial lipidomic profiles associated with cardiometabolic risk by decreasing saturated species ...
4 days agoIntermittentfastingcan offer some potentialbenefits, but some individuals should be cautious or even avoidfastingaltogether. Intermittentfasting(IF) should always be done with medical guidance, but it can help with improvinginsulinsensitivity, better heart heath, weight loss, and cellular repair.
Activation ofGLP-1receptors improvesinsulinsensitivity, reduces appetite signals, and slows gastric emptying. The result is reduced caloric intake andimprovedmetabolic regulation. When combined under clinical supervision, these therapies address weight management from complementary angles.
2 days agoRegular sauna use in obese individuals has been shown to reduce plasma LBP levels (consistent withimprovedgut barrier function), increase plasmaGLP-1(consistent with enteroendocrine activation through the propionate-GPR41 axis), and improveinsulinsensitivitymarkers in several small clinical studies.
It powers the colon cells (L-cells) that produceGLP-1, a natural hormone that helps you feel full, balance blood sugar, and burn energy efficiently.1,2,3,4 TheGLP-1pathway is a built-in system for appetite regulation, blood sugar control, and energy balance, but it only works if your gut bacteria have the right fuel. The problem?
The butyrate-GLP-1 axis plays a key role in this natural system by fueling the L-cells that produceGLP-1. In addition to supportingGLP-1signaling, butyrate also enhances energy expenditure by boosting fat oxidation and thermogenesis in brown adipose tissue. 6,7 Animal studies reinforce thesebenefits: in mice fed a high-fat diet, butyrate supplementation significantlyimprovedglucose ...
2 days agoComplete review of sauna effects oninsulinsensitivityandglucose metabolism. Covers GLUT4 upregulation, clinical trials in diabetic and healthy populations.
2 days agoGLP-1RAs + lifestyle modification -Mechanisms:GLP-1RAs reduce appetite, enhance satiety, and improve glycemic control, making adherence to calorie restriction and exercise easier; lifestyle in turn supports larger and more durable weight loss andinsulinsensitivityimprovements.
GLP-1medications significantly enhance metabolic function by improvinginsulinsensitivityandregulating blood sugar levels. This dual action helps reduce body mass and lowers the risk of developing type 2 diabetes.
Researchers suggestbenefitsmay stem from a combination of factors, including weight reduction,improvedinsulinsensitivity, reduced inflammation, and potential direct effects on heart tissue ...
6 days agoThe appetite suppression thatGLP-1medications provide can make intermittentfastingfeel achievable in a way it never has before, and the compounding metabolicbenefitsmay accelerate your progress toward a healthier weight andimprovedenergy.
The combined effects of weight loss,improvedinsulinsensitivity,andpotentially direct hepatoprotective mechanisms make pureGLP-1agonists a promising treatment for liver disease.
1. calorie restriction = decrease time to consume food normally decreases number of calories consumed 2. hormonal/endocrine/circadian altercations= longer we fast the greater glucagon is produced and increase production of adiponectin 3. alters gut microbiome = friendly flora improve how effective is intermittentfasting
Key TakeawaysGLP-1plateaus typically occur after 6-12 months when your body adapts to the medication's effects Metabolic adaptation, not medication failure, is the primary cause of weight loss stalls onGLP-1sStrategic dose adjustments, dietary changes, and exercise modifications can break through plateaus Early plateau intervention prevents long-term weight regain and maintains medication ...
4 days agoSupports healthy blood sugar levels ImprovesinsulinsensitivityProvides antioxidant and anti-inflammatorybenefitsthrough polyphenols like ellagic acid Some effects may occur within 60 minutes, making it a fast-acting metabolic support ingredient. Cinnamon Polyphenols Cinnamon is widely studied for its ability to support metabolic health.
1 day agoHere's the thing: if you frame berberine correctly — as a metabolic support compound that improvesinsulinsensitivity, modestly reduces body fat, and improves lipid markers — it becomes genuinely valuable, especially for people withinsulinresistance or metabolic syndrome. Framed as a weight loss drug? It'll disappoint you every time.
What IsGLP-1andHow Does It Relate to Binge Eating Disorder?GLP-1(glucagon-like peptide-1) is a naturally occurring hormone that plays a crucial role in regulating blood sugar levels and appetite signals throughout your body.
TodayOzempic's bioavailability from its subcutaneous injection? Close to 89%. So you have two compounds that both improveinsulinsensitivityandglucose metabolism, but through mechanisms that are so different they're barely comparable. One is a precisely engineeredGLP-1receptor agonist with near-complete bioavailability.
Feb 25, 2026WhileGLP-1agonists primarily work by mimicking the hormoneGLP-1to regulate appetite andinsulinsecretion, tirzepatide brings a second, synergistic mechanism into play with GIP. This one-two punch seems to create a more profound effect on glucose control and energy balance than targetingGLP-1alone.
Abstract Obesity and type 2 diabetes mellitus (T2DM) are global health crises with significant morbidity and mortality. Retatrutide, a novel triple receptor agonist targeting glucagon-like peptide-1 (GLP-1), Glucose-Dependent Insulinotropic Polypeptide (GIP), and glucagon receptors, represents a groundbreaking advancement in obesity and T2DM pharmacotherapy. This review synthesizes findings ...
Retatrutide is more than aGLP-1. It's a triple agonist (GLP-1+ GIP + glucagon) which means: Appetite down (GLP-1= fuller faster + longer) Blood sugar + A1Cimproved(betterinsulinresponse) Energy expenditure up (glucagon = more calories burned + more fat breakdown) That "3-pathway synergy" is why the weight loss data is so aggressive—~24% in phase 2, and up to ~28.7% average at ...